Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1993-09-15
1995-02-21
Kishore, G. S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
424489, 514183, 514963, A61K 9127, A61K 3133, A61K 950
Patent
active
053913760
ABSTRACT:
The present invention relates to method for preventing or treating cachexia in a mammal based on the administration of a therapeutically effective amount of an anti-cachexia agent. Suitable agents include ADP-ribose-polymerase inhibitors, ADP-ribose-transferase inhibitors, NADase inhibitors, nicotinamide benzamide, theophylline, thymine and analogs thereof.
REFERENCES:
patent: 4758553 (1988-07-01), Ogoshi
patent: 4781871 (1988-11-01), West, III et al.
patent: 4865836 (1989-09-01), Long, Jr.
patent: 4927623 (1990-05-01), Long, Jr.
patent: 4951673 (1990-08-01), Long
patent: 4987154 (1991-01-01), Long, Jr.
patent: 4993415 (1991-02-01), Long
patent: 5049372 (1991-09-01), Rappaport
patent: 5051353 (1991-09-01), Stratton et al.
patent: 5055479 (1991-10-01), Takiguchi et al.
Chaplin, D. J. et al. "Effect of Nicotinamide on the Microregional Heterogeneity of Oxygen Delivery within a Murine Tumor" Journal of the National Cancer Institute 82(8):672-676 (1990).
Chaplin, D. J. et al. "Nicotinamide, Flusol DA and Carbogen: a Strategy to Reoxygenate Acutely and Chronically Hypoxic Cells, In Vivo," Br. J. Cancer 63:109-113 (1991).
Nunez, R. et al. "Nicotinamide Coenzymes in Heart and Coronary Blood during Myocardial Infarction," American Journal of Pathology 226(1): 73-76 (1974).
Nunez, R. et al. "NAD Glycohydrolase Activity in Hearts with Acute Experimental Infarction," American Journal of Pathology 231(4): 1173-1177 (1976).
Shioi, Y. et al. "Selective Inhibition of Chlorophyll Biosynthesis by Nicotinamide," Archives of Biochemistry and Biophysics 267(1): 69-74 (1988).
Geyer, R. P. "Perfluorochemicals as Oxygen Transport Vehicles," Biomat., Art. Cells, Art. Org. 15(2):329-332 (1987).
Moss, G. S. et al. "Polyhemoglobin and Fluorocarbon as Blood Substitutes," Biomat., Art. Cells, Art. Org. 15(2): 333-336 (1987).
Harasaki, H. et al. "Morphological Effects of Pyridoxalated-hemoglobin-polyoxyethylene Conjugate in Dogs," Biomat., Art. Cells, Art. Org. 15(2):361 (1987).
Mattrey, R. F. and Long, D. C. "Potential Role of PFOB in Diagnostic Imaging," Investigative Radiology 23(S1): S298-S301 (1988).
Riess, J. G. "Blood Substitutes: Where Do We Stand with the Fluorocarbon Approach?," Current Surgery 45(5):365-370 (1988).
Mattrey, R. F. "Potential Role of Perfluorooctylbromide in the Detection and Characterization of Liver Lesions with CT," Radiology 170: 18-20 (1989).
Spence, R. K. "Fluosol DA-20 in the Treatment of Severe Anemia: Randomized, Controlled Study of 46 Patients," Critical Care Medicine 18(11): 1227-1230 (1990).
Investigators Brochure on Fluosol DA-20%.
Pak, C. C. and Fidler, I. J. "Liposomal Delivery of Biological Response Modifiers to Macrophages," Biotherapy 3: 55-64 (1991).
Carlson, L. A. and Oro, L. "The Effects of Nicotinic Acid on the Plasma Free Fatty Acids," Acta Medica Scandinavica 172: 641-645 (1962).
Carlson, L. A. et al. "Effect of a Single Dose of Nicotinic Acid on Plasma Lipids in Patients with Hyperlipoproteinemia," Acta Medica Scandinavica 183: 457-465 (1968).
Skidmore, I. F. et al. "Effects of Nicotinic Acid and Some of its Homologues on Lipoysis, Adenyl Cylase, Phosphodiesterase and Cyclic AMP Accumulation in Isolated Fat Cells" Pharmacology 6: 330-338 (1971).
Luria, M. H. "Effect of Low-dose Niacin on High-density Lipoprotein Cholesterol and Total Cholesterol/High-density Lipoprotein Cholesterol Ratio," Arch. Intern. Med 148: 2493-2495 (1988).
Datta, S. et al. "Enhanced Myocardial Preservation by Nicotinic Acid, an Antilipolytic Compound: mechanism of Action," Basic Res Cardiol 84: 63-76 (1989).
Superko, H. R. "Drug Therapy and the Prevention of Atherosclerosis in Humans," Am. J. Cardiol. 64: 31G-38G (1989).
Sauvage, J. P. et al. "Double-blind, Placebo-controlled, Multi-centre Trial of the Efficacy and Tolerance Niflumic Acid (`Nifluril`) Capsules in the Treatment of Tonsillitis in Adults," Current Medical Research and Opinion 11 (10): 631-637 (1990).
Physicians' Desk Reference, 45th Ed. (Medical Economics Data 1991).
Beutler, B. et al. "Purification of Cachectin, a Lipoprotein Lipase-suppressing Hormone Secreted by Endotoxin-induced RAW 264.7 Cells," J. Exp. Med. 161: 984-995 (1985).
Torti, F. M. et al. "A Macrophage Factor Inhibits Adipocyte Gene Expression: An In Vitro Model of Cachexia," Science 229: 867-869 (1985).
Dinarello, C. A. et al. "Tumor Necrosis Factor (Cachectin) is an Endogenous Pryogen and Induces Production of Interleukin 1," J. Exp. Med. 163: 1433-1450 (1986).
Price, S. R. et al. "Regulation of Lipoprotein Lipase Synthesis by Recombinant Tumor Necrosis Factor --the Primary Regulatory Role of the Hormone in 3T3-L1 Adipocytes" Archives of Biochemistry and Biophysics 251(2): 738-746 (1986).
Beutler, B. and Cerami, A. "Cachectin: More than a Tumor Necrosis Factor," The New England Journal of Medicine 316(7): 379-385 (1987).
Oliff, A. et al. "Tumors Secreting Human TNF/Cachectin Induce Cachexia in Mice," Cell 50: 555-563 (1987).
Tracey, K. J. et al. "Cachectin/Tumor Necrosis Factor Induces Cachexia, Anemia, and Inflammation," J. Exp. Med. 167: 1211-1227 (1988).
Agarwal, S. A. et al. "Tumor Necrosis Factor-mediated Cytotoxicity Involves ADP-ribosylation," The Journal of Immunology 140(12):4187-4192 (1988).
Pomposelli, J. J. et al. "Role of Biochemical Mediators in Clinical Nutrition and Surgical Metabolism," Journal of Parenteral Enternal Nutrition 12(2):212-218 (1988).
Lahdevirta, J. et al. "Elevated Levels of Circulating Cachectin/Tumor Necrosis Factor in Patients with Acquired Immunodeficiency Syndrome," The American Journal of Medicine 85:289-291 (1988).
Maury, C. P. and Teppo, A-M. "Tumor Necrosis Factor in the Serum of Patients with Systemic Lupus Erythematosus," Arthritis and Rheumatism 32(2):146-150 (1989).
Beutler, B. and Cerami, A. "The Biology of Cachectin/TNF --a Primary Mediator of the Host Response," Ann. Rev. Immunol. 7:625-655 (1989).
Perez, C. et al. "A Nonsecretable Cell Surface Mutant of Tumor Necrosis Factor (TNF) Kills by Cell-to-Cell Contact," Cell 63:251-258 (1990).
Schraufstattter, I. U. et al. "Cellular Targets of H.sub.2 O.sub.2 and HOCl Induced Injury," Basic Life Sci. 49:833-837 (1988).
Pekala, P. H. and Moss, J. "Poly ADP-ribosylation of Protein," Current Topics In Cellular Regulation 22:1-49 (1983).
Sims, J. L. et al. "Poly (ADP-ribose) Polymerase Inhibitors Preserve Nicotinamide Adenine Dinucleotide and Adenosine 5'-Triphosphate Pools in DNA-damaged Cells: Mechanism of Stimulation of Unscheduled DNA Synthesis," Biochemistry 22:5188-5194 (1983).
Berger, N. A. et al. "Poly (ADP-ribose) Polymerase Mediates the Suicide Response to Massive DNA Damage: Studies in Normal and DNA-repair Defective Cells," Japan Sci. Soc. Press, pp. 219-226 (Miwa, M. et al. eds. 1983).
Schrastratter, I. U. et al. "Hydrogen Peroxide-induced Injury of Cells and its Prevention by Inhibitors of Poly (ADP-ribose) Polymerase," Proc. Natl. Acad. Sci., U.S.A. 83:4908-4912 (1986).
Nadeau, D. and Lane, D. A. "The Cytotoxicity of Chrysotile Asbestos Fibers to Pulmonary Alveolar Macrophages. I. Effects of Inhibitors of ADP-ribosyl Transferase," Cell Biology and Toxicology 4(1):13-30 (1988).
Simpson, L. L. et al. "Production by Clostridium spiroforme of an Iotalike Toxin that Possesses Mono (ADP-ribosyl) transferase Activity: Identification of a Novel Class of ADP-ribosyltransferases," Infection and Immunity 57(1):255-261 (1989).
Pozzilli, P. et al. "Nicotinamide Increases C-peptide Secretion in Patients with Recent Onset Type I Diabetes," Diabetic Medicine 6:568-572 (1989).
August, E. M. et al. "Inhibition of Poly(Adenosine Diphosphate-ribose) Polymerase by Thymidine and Thymidine Analogues in L1210 Cells and Its Relationship to the Potentation of the Antitumor Activity of 1,3-Bis(2-chloroethyl)-1-nitrosourea but not of 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine," Cancer Research 51: 1586-1590 (1991).
Fuller et al. Int. J. Std & AIDS 2:369-370 (1991).
Long Raymond A.
Long, Jr. David M.
LandOfFree
Method for preventing and treating cachexia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing and treating cachexia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing and treating cachexia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1928550